By Sneha S K May 31 (Reuters) - Johnson & Johnson's prostate cancer drug Erleada used with hormone-blocking therapy six ...

Dr. Phillip Koo with the Prostate Cancer Foundation and Bill, who lives with prostate cancer, have all you need to know.

By doing hormone therapy up front in prostate cancer cases, the hope was to shrink the relapse rate after surgery. Results ...

June is Men’s Health Month, so it seems appropriate to begin the month by focusing on a topic specific to men’s wellness and ...

New research has found that low testosterone levels can cause extreme progression in high-grade prostate cancer. The study ...

With a new phase 3 win for Erleada (apalutamide), Johnson & Johnson is proposing a solution to a longstanding prostate cancer treatment gap. For patients with high-risk localized or locally advanced ...

ADT plus apalutamide before and after surgery significantly improved metastasis-free survi ...

Only men with a dangerous genetic variant and a family history of cancer should be offered screening, say UK advisors.

The announcement that King Charles III was admitted to a private hospital Friday to undergo a procedure for an enlarged prostate has sparked interest in what is an extremely common condition among ...

The majority of men in the UK will not be offered prostate cancer screening following a final recommendation from a committee ...

But despite this good news, the overall number of new prostate cancer cases and deaths is on the rise in the U.S.: 2014: 182,806 new prostate cancer cases 2019: 224,733 new prostate cancer cases ...

"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." Newsflash for the kings, queens, and anyone with a penis who hasn't figured it out. The real male ...